Insider Transactions in Q1 2022 at Medpace Holdings, Inc. (MEDP)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2022
|
August J. Troendle CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+11.03%
|
$9,000,000
$90.65 P/Share
|
|
Feb 23
2022
|
Susan E Burwig Exec. VP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
12,400
+38.06%
|
$347,200
$28.32 P/Share
|
|
Feb 17
2022
|
Fred B Davenport Jr Director |
BUY
Open market or private purchase
|
Indirect |
500
+20.0%
|
$72,500
$145.8 P/Share
|
|
Jan 04
2022
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,338
-0.06%
|
$710,994
$213.44 P/Share
|
|
Jan 04
2022
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
3,338
-0.06%
|
$710,994
$213.44 P/Share
|
|
Jan 03
2022
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
19,744
-0.36%
|
$4,185,728
$212.7 P/Share
|
|
Jan 03
2022
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
19,744
-0.36%
|
$4,185,728
$212.7 P/Share
|